Acidic polysaccharide CP-2 from Dioscoreae Rhizoma ameliorated acute alcoholic liver injury through the gut-liver axis and AMPK/PPAR pathway

3.0 科研~小助 2025-08-30 7 4 18.74MB 14 页 1知币
侵权投诉
Acidic polysaccharide CP-2 from Dioscoreae Rhizoma ameliorated acute
alcoholic liver injury through the gut-liver axis and AMPK/PPAR pathway
Yujun Xie
a
, Mingxing Tao
a
, Xiaodong Yan
a
, Xinxin Fan
a,b
, Alamusi Bayoude
a
, Yu Lu
b
,
Shuangli Zhao
b
, Boyang Yu
a,*
, Renshi Li
a,*
a
Jiangsu Provincial Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing
211198, China
b
Division of Pharmaceutical Cell Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 8128582, Japan
ARTICLE INFO
Keywords:
Dioscoreae Rhizoma polysaccharide
Acute alcoholic liver injury
Gut-liver axis
ABSTRACT
Dioscoreae Rhizoma polysaccharides exhibit gastrointestinal protective properties, yet their efcacy against
acute alcoholic liver injury (AALI) remains unexplored. This study identies a novel acidic heteropolysaccharide
(CP-2, Mw =8.4 ×10
3
kDa) with galactose/galacturonic acid dominance and delineates its multimodal hep-
atoprotective mechanisms. In AALI mice, CP-2 attenuated liver injury by enhancing ADH and ALDH activities
while restoring redox balance via SOD/CAT activation and MDA reduction, and suppressed inammation by
inhibiting IL-1β, IL-6, and TNF-
α
levels. Gut-liver axis modulation was achieved through intestinal barrier
reinforcement (ZO-1, Occludin, Claudin-1) and microbiota rebalancing. CP-2 could reduce gram-negative bac-
teria ([Ruminococcus]_ torques_ group and Escherichia- Shigella) and Proteobacteria abundance while enriching
Bacteroides and Akkermansia abundance, which collectively suppressed serum LPS level. In addition, CP-2 could
activate the AMPK/PPAR signaling pathway to reduce the production of fatty acids and promote their degra-
dation in AALI. CP-2 can improve AALI by adjusting the composition of gut microbiota, repairing intestinal
barrier function, decreasing systemic inammation and oxidative reactions, and regulating the AMPK/PPAR
pathway. Our ndings unveil CP-2 as a prebiotic candidate for AALI intervention and may advance functional
food development for alcohol-related hepatopathies.
1. Introduction
Alcohol consumption constitutes a widespread global public health
concern. According to recent WHO data, approximately 2.3 billion in-
dividuals consume alcohol, with an estimated 283 million (237 million
males and 46 million females) engaging in hazardous drinking patterns
[1]. Alcohol-induced liver injury, especially acute alcoholic liver injury
(AALI), ranks among the most prevalent alcohol-associated pathologies
worldwide [2]. Without timely and effective intervention, AALI pro-
gresses to advanced stages of alcoholic liver disease, culminating in
irreversible complications such as cirrhosis and brosis [3]. Conse-
quently, developing strategies to mitigate AALI has emerged as a critical
priority in public health research.
The pathogenesis of AALI may be elucidated through the gut-liver
axis, a bidirectional relationship between hepatic function and intesti-
nal homeostasis. Chronic alcohol intake disrupts gut microbiota equi-
librium, compromises intestinal barrier integrity, and elevates intestinal
permeability [4]. These alterations facilitate the translocation of lipo-
polysaccharides (LPS) from gram-negative bacteria into portal circula-
tion, triggering Kupffer cell activation and subsequent pro-inammatory
cytokine cascades that exacerbate hepatic injury [5]. Alcohol is mainly
absorbed by the intestinal canal for metabolism in liver, increasing ROS
release and a concomitant weakening of the antioxidant defense system.
This results in unbalanced oxidative status, which in turn gives rise to
oxidative stress in the liver [6]. Alcohol ingestion can also lead to dis-
turbances in liver lipid metabolism through fats synthesis increasing and
the fatty acids oxidation reducing, ultimately results in an excessive
lipids storage, a condition termed hepatic steatosis [7]. It is generally
accepted that an imbalanced gut microbiota, enhanced gut perme-
ability, hepatic inammation and oxidative stress, as well as lipid
deposition, are involved in AALI development [8]. Current therapeutic
interventions for alcohol-related hepatotoxicity, including anti-
inammatory agents (e.g., diammonium glycyrrhizinate), antioxidants
(e.g., glutathione), and hepatoprotective compounds (e.g.,
* Corresponding authors.
E-mail addresses: boyangyu59@163.com (B. Yu), li-renshi@cpu.edu.cn (R. Li).
Contents lists available at ScienceDirect
International Journal of Biological Macromolecules
journal homepage: www.elsevier.com/locate/ijbiomac
https://doi.org/10.1016/j.ijbiomac.2025.143145
Received 20 January 2025; Received in revised form 31 March 2025; Accepted 12 April 2025
International Journal of Biological Macromolecules 310 (2025) 143145
Available online 13 April 2025
0141-8130/© 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
ursodeoxycholic acid), demonstrate limited efcacy and carry risks of
adverse effects, underscoring the need for safer alternatives. This ther-
apeutic gap has intensied interest in natural bioactive compounds with
multimodal hepatoprotective properties.
Polysaccharides represent a promising class of phytochemicals
exhibiting potent antioxidant, anti-inammatory, and immunomodula-
tory activities [9]. Some polysaccharides extracted from Angelica sinensis
[10], Enteromorpha prolifera [11], and Dendrobium ofcinale [12]
demonstrated anti-AALI activity. Dendrobium huoshanense poly-
saccharides could mitigate early-stage steatosis and inammation in
AALI by modulating the fatty acid metabolism pathway [13]. Dioscoreae
Rhizoma (Dioscorea opposite Thunb.), also known as Chinese yam (CY),
has been a resourceful food for gastrointestinal protection on a global
scale [14]. It has boasted numerous biological activities, such as the
strengthening of immunity, gastrointestinal protection, antioxidation,
anti-tumor, and so on [15]. Earlier literature has shown that yam gruel
can regulate hepatic lipid metabolism disorders by activating the
AMPK/ACC/CPT-1 pathway in diabetic rats [16]. Polysaccharides,
which are among the most prevalent active ingredients in CY, have been
shown to reduce oxidative, inammatory, and anti-hyperglycaemic ef-
fects [17]. However, as a widely used resource plant, the hep-
atoprotective effect of Dioscoreae Rhizoma polysaccharide (CP) has not
been specically studied.
This study investigates the therapeutic efcacy of a novel acidic
polysaccharide from Dioscoreae Rhizoma (CP-2) in AALI models.
Through a comprehensive analysis of ethanol metabolism biomarkers,
oxidative-inammatory markers, lipid-regulatory proteins, and gut
microbiota proles, we elucidate CP-2's mechanistic role in hep-
atoprotection. This research could form the basis for the formulation and
use of CP-2 in food and medical applications.
2. Materials and methods
2.1. Materials and reagents
Anhydrous ethanol (analytical grade) was procured from Shanghai
Titan Scientic Co., Ltd. (Shanghai, China). Bifendate pills (batch
number: 230703) were sourced from Beijing Union Pharmaceutical
Factory Ltd. (Beijing, China). DEAE-52, catalase (CAT), malondialde-
hyde (MDA), superoxide dismutase (SOD), and Ethanol Assay Kit were
obtained from Beijing Solarbio Science & Technology Co., Ltd. (Beijing,
China). Alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase
(ALDH), triglyceride (TG), alanine aminotransferase (ALT), and aspar-
tate aminotransferase (AST) kits were acquired from Nanjing Jiancheng
Bioengineering Institute (Nanjing, China). Lipopolysaccharide (LPS),
cytochrome P450 family 2 subfamily E member 1 (CYP
2
E
1
), Interleukin
1β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor-
α
(TNF-
α
)
ELISA kits were purchased from Hunan Aifang Biotechnology Co., Ltd.
(Changsha, China).
2.2. The preparation of crude polysaccharide (CCP)
The Chinese yam was supplied by Jiaozuo Mingren Natural Medicine
Co., Ltd. (Jiaozuo, China). CP was prepared via hot water extraction and
ethanol precipitation [18]. Briey, 1,000 g of crushed and sieved raw
materials were mixed with 10 L of distilled water and heated at 100 C
for 1 h. The residue underwent two additional extractions under iden-
tical conditions. The ltrates were then concentrated to 1 L and
precipitated using 80 % ethanol. The precipitate was re-dissolved,
deproteinized using a mixture of chloroform (purity 99.0 %) and n-
butanol (purity 99.5 %) in a 5:1 volume ratio, decolorized by the acti-
vated carbon (Macklin Co., Ltd., Beijing, China), dialyzed (3.5 kDa
MWCO membrane, Beijing Solarbio Science & Technology Co., Ltd.,
Beijing, China), and lyophilized to obtain the crude polysaccharide
(CCP, yield 0.5 %).
2.3. The isolation and purication of CP
CP was subjected to isolation and purication using DEAE-Cellulose
(Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) [19].
Firstly, 50 mg of CCP was dissolved in 1.0 mL of distilled water and
fractionated on the column (50 cm ×2.6 cm). The column was then
eluted with 0, 0.1, 0.3, and 0.5 M NaCl solutions, resulting in the gen-
eration of an elution curve. This curve exhibited three principal peaks,
designated CP-1, CP-2, and CP-3.
2.4. Characterization of CP-2
2.4.1. Chemical composition analysis
Chemical methods were used to determine the total carbohydrate,
protein, and uronic acid content of CP-2 [2022]. The phenolsulfuric
acid method was used to determine the total carbohydrate content of CP-
2. The Coomassie brilliant blue method was used to determine the total
protein content. The m-hydroxydiphenyl colorimetry method was used
to determine the uronic acid content.
2.4.2. CP-2 molecular weight determination
An Agilent 1260 series HPLC equipped with an evaporative light-
scattering detector (ELSD) was used to determine the molecular
weight of CP-2 [21]. Dextran standards of different molecular weights
(China National Institute for the Control of Pharmaceutical and Bio-
logical Products, purity 98.0 %) for standard curves. TSK gel GMPWxl
and TSK gel G3000PWxl (Tosoh Corp., Tokyo, Japan) columns were
used for separation at a column temperature of 25 C and a ow rate of
1.0 mL/min. The mobile phase was distilled water using isocratic
elution.
2.4.3. FT-IR spectra determination
CP-2 mixed with potassium bromide powder was used to press mil-
limetre thick sheets. Fourier transform infrared (FT-IR, Shimadzu,
Japan) spectral analysis was performed in the 4000400 cm
1
region
[23].
2.4.4. Determination of the composition of CP-2 monosaccharides
CP-2 (5 mg) was dissolved in 2 mL of 3 M triuoroacetic acid, hy-
drolyzed at 120 C for 3 h, and dried with nitrogen gas. The resulting
residue was dissolved in pure water and centrifuged (12,000 rpm, 5
min). Finally, the supernate was used for high-performance anion ex-
change chromatography - pulsed amperometric detector (HPAEC-PAD,
Thermo Fisher ICS5000, USA) analysis [24]. DionexCarbopacPA20
(150 mm ×3.0 mm) column was used for separation at a column tem-
perature of 30 C and a ow rate of 0.3 mL/min. There were three
mobile phases, including H
2
O (A), 250 mM NaOH (B), and 500 mM
NaOH and 50 mM NaAc (C). Elution gradient: 98 % A: 2 % B at 023
min, 80 % A: 20 % B at 2333 min, 80 % A: 20 % C at 3346 min, 20 % A:
80 % C at 4666 min, 98 % A: 2 % B at 6680 min. Monosaccharide
standards (BoRui Saccharide Biotech Co. Ltd., purity 98.0 %) are used
to determine monosaccharide retention times. Take each mono-
saccharide standard solution and accurately congure the mixed stan-
dard solution. According to the absolute quantitative method, the
content of different monosaccharides was determined and the molar
ratio was calculated according to the molar mass of monosaccharides.
2.5. Animals and treatments
2.5.1. Experimental design
Thirty-six male ICR mice (6 weeks old) were obtained from Yangz-
hou University (Jiangsu, China) and fed according to the procedure of
the Animal Ethics Committee of China Pharmaceutical University
(protocol no. 202304-011). Mice were housed at room temperature of
25 ±1 C, relative humidity of 45.0 ±5.0 %, and a 12 h light/dark
cycle.
Y. Xie et al.
International Journal of Biological Macromolecules 310 (2025) 143145
2
Acidic polysaccharide CP-2 from Dioscoreae Rhizoma ameliorated acute alcoholic liver injury through the gut-liver axis and AMPK/PPAR pathway.pdf

共14页,预览5页

还剩页未读, 继续阅读

作者:科研~小助 分类:文献 价格:1知币 属性:14 页 大小:18.74MB 格式:PDF 时间:2025-08-30

开通VIP享超值会员特权

  • 多端同步记录
  • 高速下载文档
  • 免费文档工具
  • 分享文档赚钱
  • 每日登录抽奖
  • 优质衍生服务
/ 14
客服
关注